As shown in Fig. 3G, UNC0642 markedly decreased the metastatic capability of PC-3 cells in vivo, indicating that targeting EHMT1/2 may prevent prostate cancer progression and metastasis. This evidence concerns the gene EHMT1 and prostate cancer.